Literature DB >> 18768649

Fatal outcome of hepatitis A virus (HAV) infection in a traveler with incomplete HAV vaccination and evidence of Rift Valley Fever virus infection.

Anke Oltmann1, Stephanie Kämper, Oliver Staeck, Jonas Schmidt-Chanasit, Stephan Günther, Thomas Berg, Christina Frank, Detlev H Krüger, Jörg Hofmann.   

Abstract

Hepatitis A virus (HAV) infection is rarely fatal except in patients with chronic liver disease. In the case reported here, an elderly women died of HAV infection 12 years after incomplete HAV vaccination. The possible role of a concordant Rift Valley fever virus infection acquired in Kenya is discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18768649      PMCID: PMC2576571          DOI: 10.1128/JCM.01102-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Characterization of hepatitis A virus isolates from subgenotypes IA and IB in Rio de Janeiro, Brazil.

Authors:  Vanessa S de Paula; Marcia L Baptista; Elisabeth Lampe; Christian Niel; Ana M C Gaspar
Journal:  J Med Virol       Date:  2002-01       Impact factor: 2.327

2.  Acute hepatitis A virus infection: a review of prognostic factors from 25 years experience in a tertiary referral center.

Authors:  Ioannis Kyrlagkitsis; Matthew E Cramp; Heather Smith; Bernard Portmann; John O'Grady
Journal:  Hepatogastroenterology       Date:  2002 Mar-Apr

3.  Liver-derived cytotoxic T cells in hepatitis A virus infection.

Authors:  A Vallbracht; K Maier; Y D Stierhof; K H Wiedmann; B Flehmig; B Fleischer
Journal:  J Infect Dis       Date:  1989-08       Impact factor: 5.226

4.  Rift Valley fever outbreak--Kenya, November 2006-January 2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-02-02       Impact factor: 17.586

5.  Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Anthony E Fiore; Annemarie Wasley; Beth P Bell
Journal:  MMWR Recomm Rep       Date:  2006-05-19

6.  Midzonal lesions in yellow fever: a specific pattern of liver injury caused by direct virus action and in situ inflammatory response.

Authors:  Juarez A S Quaresma; Maria I S Duarte; Pedro F C Vasconcelos
Journal:  Med Hypotheses       Date:  2006-05-02       Impact factor: 1.538

7.  Viral and clinical factors associated with the fulminant course of hepatitis A infection.

Authors:  Guilhermo Rezende; Anne Marie Roque-Afonso; Didier Samuel; Michele Gigou; Elisabeth Nicand; Virginie Ferre; Elisabeth Dussaix; Henri Bismuth; Cyrille Féray
Journal:  Hepatology       Date:  2003-09       Impact factor: 17.425

8.  [The molecular epidemiology of hepatitis A in The Netherlands; the usefulness of typing isolated viral strains].

Authors:  S M Bruisten; G M S Tjon; J A R van den Hoek; C J Wijkmans; H M Götz; R A Coutinho
Journal:  Ned Tijdschr Geneeskd       Date:  2007-12-15

9.  Immunogenicity of combined hepatitis A and B vaccine in elderly persons.

Authors:  Bernd Wolters; Ulrich Junge; Stefan Dziuba; Michael Roggendorf
Journal:  Vaccine       Date:  2003-09-08       Impact factor: 3.641

10.  Hepatitis A vaccine: indirect evidence of immune memory 12 years after the primary course.

Authors:  Koen Van Herck; Pierre Van Damme; Marc Lievens; Michel Stoffel
Journal:  J Med Virol       Date:  2004-02       Impact factor: 2.327

View more
  3 in total

1.  Emergence of zoonotic arboviruses by animal trade and migration.

Authors:  Martin Pfeffer; Gerhard Dobler
Journal:  Parasit Vectors       Date:  2010-04-08       Impact factor: 3.876

2.  Paving the way for human vaccination against Rift Valley fever virus: A systematic literature review of RVFV epidemiology from 1999 to 2021.

Authors:  Keli N Gerken; A Desirée LaBeaud; Henshaw Mandi; Maïna L'Azou Jackson; J Gabrielle Breugelmans; Charles H King
Journal:  PLoS Negl Trop Dis       Date:  2022-01-24

Review 3.  Identification and distribution of pathogens coinfecting with Brucella spp., Coxiella burnetii and Rift Valley fever virus in humans, livestock and wildlife.

Authors:  Earl A Middlebrook; Alicia T Romero; Bernard Bett; Daniel Nthiwa; Samuel O Oyola; Jeanne M Fair; Andrew W Bartlow
Journal:  Zoonoses Public Health       Date:  2022-01-15       Impact factor: 2.954

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.